0 participants
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-11-02
- Start Date:
- 2010-10-31
- Completion:
- 2012-12-31
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet